Cancer, Bleeding Risks At The Heart Of Prasugrel Review; Could Limiting Use Help?

FDA discusses labeling to restrict prasugrel use to one week or one month; less frequent dosing regimen would dampen sales projections.

More from Archive

More from Pink Sheet